20.78
-0.12(-0.57%)
Currency In CNY
Address
East Section of Building C1-2
Nanjing, 210000
China
Phone
86 25 8577 1179
Website
Sector
Healthcare
Industry
Biotechnology
Employees
2867
First IPO Date
November 15, 2021
| Name | Title | Pay | Year Born |
| Kai Shen | Accounting Supervisor | 0 | N/A |
| Guo Yang Zhang | Chairman of the Supervisory Board & Head of Human Resources Department | 0 | 1989 |
| Jin Huang | Board Secretary | 0 | 1991 |
| Lijun Zhang | Deputy GM & Director | 0 | 1983 |
| Xiao Mei Hu | Deputy GM & Director | 0 | 1967 |
| Wen Xin Bi | Chief Financial Officer | 0 | 1976 |
| Xiaoyu Xu | Deputy General Manager | 0 | 1984 |
| Lin Cao | Chairman of the Board & GM | 0 | 1979 |
Nanjing Vazyme Biotech Co., Ltd., a biotechnology company, engages in the research, development, and production of enzymes, antigens, antibodies, and polymer organic materials. The company offers scientific research reagents, such as PCR clone point mutation, nucleic acid extraction, reverse transcription, qPCR, cell/protein, gene editing series, and instant granules; high-throughput sequencing library construction reagents, including DNA and RNA library, single cell epigenetic, magnetic, quantitative series, and cell-free DNA storage and extractions; and biomedical reagents and services. It serves scientific research institutions, high-throughput sequencing service companies, molecular diagnostic reagent manufacturers, pharmaceutical companies, CRO companies, hospitals, and other medical institutions. The company was founded in 2012 and is based in Nanjing, China.